Diphenhydramine in the treatment of akathisia induced by prochlorperazine

Journal of Emergency Medicine

Volumn 26, Issue 3, 2004, Pages 265-270

  Vinson, David R ^a,b  

^a MADIGAN ARMY MEDICAL CENTER   (United States)

^b KAISER PERMANENTE MEDICAL CENTER   (United States)

Author keywords

Akathisia; Antiemetics; Diphenhydramine; Prochlorperazine

Indexed keywords

DIPHENHYDRAMINE; PROCHLORPERAZINE;

ADOLESCENT; ADULT; AGED; AKATHISIA; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; FEMALE; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; NAUSEA; PRIORITY JOURNAL; TREATMENT OUTCOME; VOMITING;

ADOLESCENT; ADULT; AKATHISIA, DRUG-INDUCED; ANTIPARKINSON AGENTS; COHORT STUDIES; DIPHENHYDRAMINE; DOPAMINE ANTAGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; PROCHLORPERAZINE; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 1542719056     PISSN: 07364679     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jemermed.2003.11.011     Document Type: Article

References (27)

1. Smithy G., Homburger F. Prochlorperazine for the treatment of nausea and vomiting in patients with advanced cancer and other chronic diseases. N Engl J Med. 256:1957;27-28.
2. Ernst A.A., Weiss S.J., Park S., Takakuwa K.M., Diercks D.B. Prochlorperazine versus promethazine for uncomplicated nausea and vomiting in the emergency department a randomized, double-blind clinical trial. Ann Emerg Med. 36:2000;89-94.
3. Vinson D.R. Treatment patterns of isolated benign headache in US emergency departments. Ann Emerg Med. 39:2002;215-222.
4. Seim M.B., March J.A., Dunn K.A. Intravenous ketorolac vs intravenous prochlorperazine for the treatment of migraine headaches. Acad Emerg Med. 5:1998;573-576.
5. Coppola M., Yealy D.M., Leibold R.A. Randomized, placebo-controlled evaluation of prochorperazine versus metoclopramide for emergency department treatment of migraine headache. Ann Emerg Med. 26:1995;541-546.
6. Kabbouche M.A., Vockell A.B., LeCates S.L., Powers S.W., Hershey A.D. Tolerability and effectiveness of prochlorperazine for intractable migraine in children. Pediatrics. 107:2001;e62.
7. Bakheit A. The syndrome of motor restlessness - a treatable but unrecognized disorder. Postgrad Med J. 73:1997;529-530.
8. Chung W.S.D., Chiu H.F.K. Drug-induced akathisia revisited. Br J Clin Pract. 50:1996;270-278.
9. Drotts D.L., Vinson D.R. Prochlorperazine induces akathisia in emergency patients. Ann Emerg Med. 34:1999;469-475.
10. Vinson D.R., Drotts D.L. In reply. [to akathisia and prochlorperazine] Ann Emerg Med. 36:2000;170-171.
11. Vinson D.R., Migala A.F., Quesenberry C.P. Jr. Slow infusion for the reduction of akathisia induced by prochlorperazine a randomized controlled trial. J Emerg Med. 20:2001;113-119.
12. Collins R.W., Jones J.B., Walthall J.D., et al. Intravenous administration of prochlorperazine by 15-minute infusion versus 2-minute bolus does not affect the incidence of akathisia a prospective, randomized, controlled trial. Ann Emerg Med. 38:2001;491-496.
13. Vinson D.R., Drotts D.L. Diphenhydramine for the prevention of akathisia induced by prochlorperazine a randomized, controlled trial. Ann Emerg Med. 37:2001;125-131.
14. Vinson D.R. Akathisia problematic but preventable. Ann Emerg Med. 39:2002;576.
15. Vinson D.R., Hurtado T.R., Banwert L., Vandenberg J.T. Variations among emergency departments in the treatment of benign headache. Ann Emerg Med. 41:2003;90-97.
16. Sachdev P. A rating scale for acute drug-induced akathisia development, reliability, and validity. Biol Psychiatry. 35:1994;263-271.
17. Miller C.H., Fleischhacker W.W. Managing antipsychotic-induced acute and chronic akathisia. Drug Saf. 22:2000;73-81.
18. Holloman L.C., Marder S.R. Management of acute extrapyramidal effects induced by antipsychotic drugs. Am J Health Syst Pharm. 54:1997;2461-2477.
19. Sachdev P., Loneragan C. Intravenous benztropine and propanolol challenges in acute neuroleptic-induced akathisia. Clin Neuropharmacol. 16:1993;324-331.
20. Gagrat D., Hamilton J., Belmaker R.H. Intravenous diazepam in the treatment of neuoloeptic-induced acute dystonia and akathisia. Am J Psychiatry. 135:1978;1232-1233.
21. Fleischhacker W.W., Roth S.D., Kane J.M. The pharmacologic treatment of neuroleptic-induced akathisia. J Clin Psychopharmacol. 10:1990;12-21.
22. Schreibman D.L. Treatment of a delayed reaction to droperidol with diphenhydramine. Anesth Analg. 71:1990;105.
23. Agostini J.V., Leo-Summers L.S., Inouye S.K. Cognitive and other adverse effects of diphenhydramine use in hospitalized older patients. Arch Intern Med. 161:2001;2091-2097.
24. 1-receptor antagonists. Clin Exp Allergy. 26:1996;1092-1097.
25. 1 receptor antagonists. Ann Allergy Asthma Immunol. 74:1995;419-426.
26. 2 receptor antagonists. Ann Emerg Med. 41:2003;280.
27. Taylor W.B., Bateman D.N. Preliminary studies of the pharmacokinetics and pharmacodynamics of prochlorperazine in healthy volunteers. Br J Clin Pharmacol. 23:1987;137-142.